Semaglutide

A GLP-1 receptor agonist originally developed for type 2 diabetes, now widely prescribed for weight management. Reduces appetite and slows gastric emptying.

Details

Category
weight-loss
Administration
Subcutaneous injection (weekly)
Prescription Required
Yes
Also known as
Ozempic, Wegovy

Common Uses